| Today's Open | $26.50 |
|---|---|
| Previous Close | $26.62 |
| Daily Range | $25.97 - $26.89 |
| 52-Week Range | $22.02 - $38.27 |
| Market Cap | $2.1B |
| P/E Ratio | 16.96 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 3,529,282 |
| Average Daily Volume | 2,554,846 |
| Current FY EPS | $1.66 |
Sector
Services
Industry
Diversified Services
Myriad Genetics (MYGN) Description
Myriad Genetics is focused on developing and marketing novel molecular diagnostic products. Website: http://www.myriad.com/
News & Commentary
Supreme Court Lets the Gene Out of the Bottle
Will this week's Supreme Court ruling on gene patents release some biotech magic?Why Myriad Genetics Shares Swooned Again
A Supreme Court ruling hangover and a flurry of analyst activity sends Myriad shares back under the covers.MYGN's Top Competitors
(-0.68%)
(2.44%)
(1.78%)
(1.47%)

$0.07
(0.26%)